PE102699A1 - ANTI-ACID AND PAPAINA COMBINATION - Google Patents

ANTI-ACID AND PAPAINA COMBINATION

Info

Publication number
PE102699A1
PE102699A1 PE1998000622A PE00062298A PE102699A1 PE 102699 A1 PE102699 A1 PE 102699A1 PE 1998000622 A PE1998000622 A PE 1998000622A PE 00062298 A PE00062298 A PE 00062298A PE 102699 A1 PE102699 A1 PE 102699A1
Authority
PE
Peru
Prior art keywords
compositions
acidity
reduce
papaya
ingredients
Prior art date
Application number
PE1998000622A
Other languages
Spanish (es)
Inventor
Constantine Georgiades
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE102699A1 publication Critical patent/PE102699A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

QUE COMPRENDE: A) UNA O MAS COMPOSICIONES QUE REDUCEN LA ACIDEZ GASTRICA, QUE SE ELIGEN DE ENTRE: COMPOSICIONES QUE REDUCEN LA CONCENTRACION INTRAGASTRICA DEL HIDROGENION MEDIANTE LA NEUTRALIZACION QUIMICA, ANTAGONISTAS DEL RECEPTOR H2, COMPUESTOS DE BISMUTO, ENTRE OTROS; Y B) UNA COMPOSICION EXTRAIDA DE LA PAPAYA, QUE COMPRENDE PREFERENTEMENTE UNA O MAS ENZIMAS PROTEOLITICAS TALES COMO PAPAINA, QUIMOPAPAINA Y PROTEINASA III DE PAPAYA. SE REFIERE TAMBIEN A UN METODO PARA PREPARAR LA COMPOSICION ANTERIORMENTE DESCRITA, QUE COMPRENDE: 1) MEZCLAR UNO O MAS COMPOSICIONES QUE REDUCEN LA ACIDEZ GASTRICA QUE SE ENCUENTRAN EN FORMA SECA, EXTRACTO DE PAPAYA SECA Y DEMAS INGREDIENTES SECOS ELEGIDOS DEL GRUPO FORMADO POR EXCIPIENTES, LIGANTES, ALMIDONES, Y AZUCARES; 2) MEZCLAR MINUCIOSAMENTE LOS INGREDIENTES DEL PASO (1); Y 3) PREPARAR LOS INGREDIENTES DEL PASO (2) EN LA FORMA DE POLVO; Y ADICIONALMENTE COMPRENDE EL PASO DE COMPRIMIR DICHO POLVO PARA FORMAR UNA PASTILLA O COMPRIMIDO. LA PRESENTE COMPOSICION QUE ALIVIA EL MALESTAR ESTOMACAL TIENE USO EN EL TRATAMIENTO DE SINTOMAS DE SECRESION EXCESIVA DE ACIDO GASTRICO, TAL COMO ACIDEZ, DOLOR DE ESTOMAGO Y SIMILARESWHICH INCLUDES: A) ONE OR MORE COMPOSITIONS THAT REDUCE GASTRIC ACIDITY, WHICH ARE CHOSEN FROM: COMPOSITIONS THAT REDUCE THE INTRAGASTRIC CONCENTRATION OF HYDROGENION THROUGH CHEMICAL NEUTRALIZATION, ANTAGONISTS OF THE H2 RECEPTOR, OTHER COMPUTERS; AND B) A COMPOSITION EXTRACTED FROM PAPAYA, PREFERABLY INCLUDING ONE OR MORE PROTEOLYTIC ENZYMES SUCH AS PAPAINE, CHEMOPAPAIN AND PROTEINASE III FROM PAPAYA. IT ALSO REFERS TO A METHOD FOR PREPARING THE ABOVE-DESCRIBED COMPOSITION, WHICH INCLUDES: 1) MIXING ONE OR MORE COMPOSITIONS THAT REDUCE GASTRIC ACIDITY, WHICH ARE FOUND INCIDENT, INGREDIENT, AND SO MUCH INGREDIENT. BINDERS, STARCHES, AND SUGARS; 2) MIX THE INGREDIENTS OF THE STEP (1) THOROUGHLY; AND 3) PREPARE THE INGREDIENTS OF STEP (2) IN THE FORM OF POWDER; AND ADDITIONALLY UNDERSTANDS THE STEP OF COMPRESSING SUCH POWDER TO FORM A PILL OR TABLET. THE PRESENT COMPOSITION THAT RELIEVES STOMACH DISCOMFORT HAS USE IN THE TREATMENT OF SYMPTOMS OF EXCESSIVE SECRETION OF GASTRIC ACID, SUCH AS ACIDITY, STOMACH PAIN AND SIMILAR

PE1998000622A 1997-07-15 1998-07-15 ANTI-ACID AND PAPAINA COMBINATION PE102699A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5254397P 1997-07-15 1997-07-15

Publications (1)

Publication Number Publication Date
PE102699A1 true PE102699A1 (en) 1999-11-05

Family

ID=21978305

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000622A PE102699A1 (en) 1997-07-15 1998-07-15 ANTI-ACID AND PAPAINA COMBINATION

Country Status (9)

Country Link
EP (1) EP1001796A1 (en)
JP (1) JP2002509539A (en)
AR (1) AR016514A1 (en)
AU (1) AU8296898A (en)
BR (1) BR9809419A (en)
CA (1) CA2286357A1 (en)
PE (1) PE102699A1 (en)
WO (1) WO1999003486A1 (en)
ZA (1) ZA986247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083619A (en) * 1998-07-15 2000-03-28 Oju Seiyaku:Kk Health food and its preparation
BRPI0006503B1 (en) * 2000-02-04 2017-05-09 Biolab Sanus Farmacêutica Ltda gel, cream, aerosol, spray, liquid and lyophilized composition of papain-based carrier
WO2007010547A1 (en) * 2004-11-04 2007-01-25 Abhoy Sankar Arora A phyto-medicine and a process for the preparation thereof
GB0820846D0 (en) * 2008-11-14 2008-12-24 Carson John W Improved proteinaceous digestates
IT201700090582A1 (en) * 2017-08-04 2019-02-04 Neilos S R L Composition for use in the prevention and / or treatment of gastric or gastroesophageal disorders.

Also Published As

Publication number Publication date
EP1001796A1 (en) 2000-05-24
WO1999003486A1 (en) 1999-01-28
JP2002509539A (en) 2002-03-26
AU8296898A (en) 1999-02-10
AR016514A1 (en) 2001-07-25
CA2286357A1 (en) 1999-01-28
ZA986247B (en) 1999-02-05
BR9809419A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
MXPA03004780A (en) Novel sulfamides and their use as endothelin receptor antagonists.
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
TR200101347T2 (en) Preparation process of oral calcium compositions.
NO20003698L (en) Oral compositions
TR200102648T2 (en) Compositions that support growth
NO20034230L (en) 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists
UY25611A1 (en) SOLID ORAL DOSAGE FORMS FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES
MXPA05010137A (en) Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists.
IL162851A0 (en) 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
US1716035A (en) Tooth paste
PE102699A1 (en) ANTI-ACID AND PAPAINA COMBINATION
IT1170215B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF STATES OF ACUTE RENAL INSUFFICIENCY
ES269650A1 (en) Silica-gel powder tablet compositions
MXPA04001252A (en) Novel benzo-fused heterocycles as endothelin antagonisits.
PL80355B1 (en)
MXPA03000430A (en) Novel arylethene-sulfonamides.
KR101869976B1 (en) A cosmetic composition of peel-off type pack used by shaking
JP2010120909A (en) External application agent, external application cream and external application gel
GB895398A (en) Improvements in and relating to plaster compositions
TR200103354T2 (en) IL-8 Receptor antagonists
MXPA02006250A (en) Butyne diol derivatives.
CN101869628A (en) Medicament for treating periodontitis and preparation method thereof
JP2938355B2 (en) Pills
US1335246A (en) Process of making soap
GB109056A (en) Improvements in the Preparation of Catalytic Substances from Natural Ores Containing Iron Oxide which Contains Water of Hydration.

Legal Events

Date Code Title Description
FD Application declared void or lapsed